MeSH term
Frequency | Condition_Probility | Animals | 4 | 0.0 |
Carrier Proteins/*genetics | 2 | 0.0 |
Chromosome Fragile Sites | 2 | 1.0 |
Comparative Study | 2 | 0.0 |
Exons/genetics | 2 | 0.0 |
Humans | 18 | 0.0 |
Introns/genetics | 2 | 0.0 |
Mice | 4 | 0.0 |
Neoplasm Proteins/*genetics | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 10 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 10 | 0.0 |
Adult | 2 | 0.0 |
Base Sequence | 5 | 0.0 |
Carrier Proteins/*genetics/metabolism | 2 | 0.0 |
Chromosomes, Human, Pair 16/genetics | 2 | 2.0 |
Female | 4 | 0.0 |
Gene Deletion | 3 | 0.0 |
*Genes, Tumor Suppressor | 4 | 0.0 |
Loss of Heterozygosity | 3 | 0.0 |
Middle Aged | 2 | 0.0 |
Molecular Sequence Data | 3 | 0.0 |
Neoplasm Proteins/*genetics/metabolism | 3 | 2.0 |
RNA, Messenger/biosynthesis/genetics | 3 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 4 | 0.0 |
Transfection | 4 | 0.0 |
Tumor Cells, Cultured | 3 | 0.0 |
Alternative Splicing | 3 | 0.0 |
DNA Methylation | 4 | 0.0 |
Exons | 2 | 0.0 |
Green Fluorescent Proteins | 2 | 0.0 |
Luminescent Proteins/genetics/metabolism | 2 | 1.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
Amino Acid Sequence | 2 | 0.0 |
Chromosomes, Human, Pair 16/*genetics | 2 | 2.0 |
Cloning, Molecular | 2 | 0.0 |
DNA Mutational Analysis | 4 | 0.0 |
Homozygote | 2 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
Immunohistochemistry | 3 | 0.0 |
Mutation | 2 | 0.0 |
Oxidoreductases/*genetics/metabolism | 2 | 10.0 |
RNA, Neoplasm/genetics/metabolism | 2 | 1.0 |
Cell Transformation, Neoplastic | 2 | 0.0 |
*Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Genes, Tumor Suppressor | 2 | 0.0 |
Blotting, Western | 3 | 0.0 |
Cell Line, Tumor | 6 | 0.0 |
Cell Line | 4 | 0.0 |
Phosphorylation | 2 | 0.0 |
Protein Binding | 3 | 0.0 |
Chromosome Fragile Sites/*genetics | 2 | 33.0 |
Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Oxidoreductases/genetics/*metabolism | 2 | 10.0 |
Male | 2 | 0.0 |
Immunoblotting | 2 | 0.0 |
Subcellular Fractions/metabolism | 2 | 0.0 |
DNA Primers | 2 | 0.0 |
In Situ Hybridization, Fluorescence | 2 | 0.0 |
